Amy Schacterle
Chief Operating Officer en SAGE THERAPEUTICS, INC. .
Perfil
En la actualidad, Amy Schacterle ocupa el cargo de Vicepresidenta Senior de Investigación y Estrategia de Desarrollo en SAGE Therapeutics, Inc. En su anterior carrera, la Dra. Schacterle fue Vicepresidenta de Asuntos Reglamentarios en Sunovion Pharmaceuticals, Inc. Se licenció en el Instituto Politécnico Rensselaer y se doctoró y graduó en la Universidad de Virginia.
Cargos activos de Amy Schacterle
| Empresas | Cargo | Inicio |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Chief Operating Officer | 01/04/2020 |
Antiguos cargos conocidos de Amy Schacterle.
| Empresas | Cargo | Fin |
|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | General Counsel | 01/01/2014 |
Formación de Amy Schacterle.
| University of Virginia | Doctorate Degree |
| Rensselaer Polytechnic Institute | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Amy Schacterle
